IQVIA Holdings Inc. (LON:0JDM)
209.62
-1.45 (-0.69%)
At close: Nov 7, 2025
IQVIA Holdings Revenue
IQVIA Holdings had revenue of $4.10B USD in the quarter ending September 30, 2025, with 5.24% growth. This brings the company's revenue in the last twelve months to $15.90B, up 3.85% year-over-year. In the year 2024, IQVIA Holdings had annual revenue of $15.41B with 2.81% growth.
Revenue (ttm)
$15.90B
Revenue Growth
+3.85%
P/S Ratio
2.30
Revenue / Employee
$180.73K
Employees
88,000
Market Cap
27.22B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15.41B | 421.00M | 2.81% |
| Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
| Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
| Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
| Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
IQVIA Holdings News
- 2 days ago - Oakmark Concentrated Strategy: 6 Stocks That Raised Guidance And Drove Innovation - Seeking Alpha
- 3 days ago - IQVIA Holdings Inc. (IQV) Appoints Dr. William G. Kaelin Jr. to Board of Directors - GuruFocus
- 3 days ago - Dr. William G. Kaelin Jr. joins IQVIA Board of Directors - Business Wire
- 5 days ago - IQV Stock Downgraded: Analyst Rating Update and Price Target Raised | IQV Stock News - GuruFocus
- 9 days ago - IQVIA Holdings Inc (IQV) Q3 2025 Earnings Call Highlights: Record Free Cash Flow and Strong ... - GuruFocus
- 10 days ago - Citigroup Raises IQVIA (IQV) Price Target Amid Neutral Rating | IQV Stock News - GuruFocus
- 10 days ago - IQV: UBS Raises Price Target to $250, Maintains Buy Rating | IQV Stock News - GuruFocus
- 10 days ago - Stifel Raises Price Target for IQVIA Holdings (IQV) to $254, Maintains Buy Rating | IQV Stock News - GuruFocus